bioMérieux Recognized as Top 1% by S&P Global
March 27, 2025
bioMérieux is honored to be recognized in the top 1% of the S&P Global Sustainability Yearbook 2025, achieving a score of 70/100 in the Health Care Equipment & Supply segment. Out of 7,690 assessed companies across 62 industries, only 780 top performers have received this distinction, highlighting their excellence in sustainable business practices.
Furthermore, bioMérieux was ranked 1st in the sector of healthcare equipment and Supply by the Dow Jones Sustainability Index (DJSI) through the S&P Global Corporate Sustainability Assessment. bioMérieux first joined the DJSI in 2021 and has proudly risen to the top position in just four years! This recognition underscores the company’s strong commitment to Corporate Social Responsibility, reinforcing its mission to create a positive impact worldwide while preserving the planet as a healthy place to live.
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
